Predicting Hypertensive Disease in the First Trimester of Pregnancy: Risk Models and Analysis of Serum D-dimer Levels Combined with Plasma Pregnancy-Associated Protein A, Free <i>β</i>-Subunit of Human Chorionic Gonadotropin, and Fetal Nuchal Translucency

<div>Comparison of DD, PAPP-A, free <i>β</i>-hCG, and NT MoM among the four groups. (a) DD MoM; (b) PAPP-A MoM; (c) free <i>β</i>-hCG MoM; (d) NT MoM. DD: D-dimer; PAPP-A: pregnancy-associated plasma protein A; free <i>β</i>-hCG: free beta human chorionic gonadotropin; NT: nuchal translucency; GH: gestational hypertension; PE: preeclampsia; SPE: severe preeclampsia; MoM: multiple of median.</div>

BioMed Research International

fig1

Figure 1

Figure 1: Predicting Hypertensive Disease in the First Trimester of Pregnancy: Risk Models and Analysis of Serum D-dimer Levels Combined with Plasma Pregnancy-Associated Protein A, Free <i>β</i>-Subunit of Human Chorionic Gonadotropin, and Fetal Nuchal Translucency 

Figure 1 | Predicting Hypertensive Disease in the First Trimester of Pregnancy: Risk Models and Analysis of Serum D-dimer Levels Combined with Plasma Pregnancy-Associated Protein A, Free β-Subunit of Human Chorionic Gonadotropin, and Fetal Nuchal Translucency 